chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Upon reviewing the list of possible allergies related to the Pfizer vaccine components, found out that employee was allergic to Paclitaxel.   Pt administered second dose Pfizer vaccine at 7:06 AM.  Pt was talking on the phone, speech was normal. Upon consultation, Benadryl was given prophylactically at 7:15 AM.  The following vital signs prior to administration of Benadryl BP 128, 78, RR 16, HR 72, SpO2 98%. Pt stayed for 50 minutes post- Benadryl and remained in no distress.
Developed fatigue, myalgias, and loose stool on the evening of 3/1.  On 3/2 developed hoarse voice and sore throat.  Mild fatigue and myalgias persisted.
Pfizer-BioNTech COVID-19 Vaccine EUA large pimple-like bumps in sets of 2 on opposite shoulder and shoulder blade (left) large pimple-like bumps on neck, left breast, left upper/outer thigh, left shin, right upper/outer thigh, behind left ear
Developed redness, itching in the afternoon vaccine given in a.m. Hard, warm to touch, redness to upper arm shot was given. Spreading at Urgent Care. Given ROCEPHIN for possible cellulitis at Urgent Care. Given BENADRYL, prednisone.
red,  swollen , itchy, hot to the touch I was treated with prednisone  symptoms subsided by the forth day of treatment
Patient came in to our office on 10/5/18 with complaints of severe pain and arm/hand numbness after his SHINGRIX vaccine. It was given on 10/1/18 at pharmacy and started hurting immediately after. After examining patient it looked like the vaccine was given incorrectly, it seems as if it was given more posteriorly than it should have been most likely hitting nerves. His shoulder and arm was in severe pain and his fingers were completely numb. We gave him Prednisone and an antibiotic and those seemed to help within a few days. Reported the incident to the pharmacy and they are looking into it.
This spontaneous report as received from a Doctor of Pharmacist refers to a female patient in her mid 50's. On an unknown date, the patient was vaccinated with a dose of 0.65 ml of ZOSTAVAX (Lot number was not provided) subcutaneously. No other co-suspects were reported. No concomitant medications were reported. The doctor of pharmacist reported that on an unknown date the patient who got the ZOSTAVAX experienced "swelling and a ring starting from the shoulder down to their elbow. The ring of redness was around the injection site and it lasted about 7 to 10 days". The doctor of pharmacist also mentioned that "other than it looking bad, the patient said it was not too uncomfortable and did not hurt too bad." The patient did check with her physician and the physician was not concerned about it. No treatment was given for the events. On an unknown date, the patient recovered from all the events. It was unknown if lab diagnostic studies were performed. Additional information has been requested.
patient got flu after receiving the flu shot; Initial information received on 13-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer (patient) via social media.    This case involves a patient (age and gender unknown) who experienced flu (influenza), while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious flu (influenza) (Unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.   There will be no information available on batch number for this case.
5 or 6 hrs after vaccines - muscle pain in arm. Whole arm became swollen, and bright red (5-6 hrs after shot, continued for 1 week). Swollen like a grapefruit. Had chills and sweats, nauseous, weak, headache. Chief complaint severe swelling.
VASOVAGEL SYCOPE IMMEDIATELY AFTER INJECTION. PATIENT BLACKED OUT FOR A MOMENT THEN FELT DIZZY HANDS TINGLED.  SWEATY.  FELT BETTER UPON DRINKING WATER AND LAYING ACCOSS 2 CHAIRS.  DID NOT FALL OR OTHERWISE INJURED.
Bumps--hives and redness.  very itchy "like bugs crawling all over"   She complained for about an hour, took a bath, worse.  Took Benadryl and it went away.   Today she broke out again.
Night of vaccine, patient was screaming inconsolably and could not sleep (which has never happened other than that night). The next morning, he had bright red welts on his cheeks. Over the next few days, those welts began to leak puss.
01/04/22 presents to EC ED "via EMS from his living facility due to aggressive behavior". PMHx of "tobacco use, paranoid schizophrenia, morbid obesity, HTN, prior pulmonary embolism, atrial fibrillation on Eliquis, and COPD"
A report has been received from a Health Professional concerning a 7 year old, Female subject, who had been received FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on an unknown date. Medical Assistant reported that the patient received expired FLUMIST quadrivalent on 02-Dec-2013 and did not reported any symptoms. The outcome of the event of administration of expired product is unknown. The report was considered to be non-serious.
w/in 5 mins p/vax 11NOV93 pt tongue & face became numb, ear itched, BP (systolic) 180. h/a, flushing; p/5 more mins labile then recurrence off & on for 30 mins; pt c/o felt jittery inside; rx'd w/Phenergan & Epi (15 mins) into event;
Redness  of the face; Tightness of the face; This spontaneous case was reported by a physician and describes the occurrence of ERYTHEMA (Redness  of the face) and MUSCLE TIGHTNESS (Tightness of the face) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LOSARTAN for an unknown indication.    On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Aug-2021, the patient experienced ERYTHEMA (Redness  of the face) and MUSCLE TIGHTNESS (Tightness of the face). At the time of the report, ERYTHEMA (Redness  of the face) and MUSCLE TIGHTNESS (Tightness of the face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient took a medication that causes angioedema (Losartan for more than a year).  No treatment information was provided.
Narrative:  Patient had a stroke 18 hours after admission to the hospital which was 5.5 days after his second Pfizer vaccination. He had multiple stroke risk factors and was non-adherent with medications for 4-5 days prior to stroke, and poorly adherent prior to that. He was admitted to the hospital on 2/21/21 for an episode of weakness when going to the bathroom in the night on 2/20/21 and being unable to get up. Brought by ambulance to the hospital. Patient suffered another stroke while in rehab in April and passed away 4/24/21.
Patient was administered shingrix, patient noticed on her left arm from injection site down her arm was swollen. she described it as red swollen and some discomfort, after a few days the swelling subsided however she noticed it was unusual
Information was received on 14-OCT-2016 from a medical assistant who reported that multiple unspecified patients received either VARIVAX (confirmed lot no. M028553, expiration 07-JUN-2018; M004330, 26-JAN-2018; M009766, 23-FEB-2018; M017290, 07-APR-2018; M024683, 18-MAY-2018), or PROQUAD (confirmed M006107, expiration 01-AUG-2017; M007962, 15-AUG-2017; M017337, 05-OCT-2017; M029599, 10-DEC-2017) that were improperly stored. No adverse effects reported. All fields pertain to all unspecified patients and all products. No further information was provided. This is one of two reports. Additional information has been requested.
Narrative: COVID infection following completion of COVID vaccine series 02/24/21 COVID vaccine dose #1 03/17/21 COVID vaccine dose #2 07/15/21 Pt calls reporting cough, low grade fever (99.3), myalgia, nasal congestion, fatigue, sneezing; states this happens frequently with history of asthma and testing being done for lupus; rx given for doxycycline, medrol dose pack, benzonatate for acute respiratory infection, and diflucan for yeast infection prophylaxis; advised to seek COVID testing and quarantine 07/16/21 Pt calls reporting testing COVID POSITIVE 07/17/21 Pt states she became ill starting 07/11 and progressively got worse with lung tightness, fever, and nasal congestion; reports feeling "pretty sick" but a little better today; exposed to sick son 1-2 weeks ago but he was not tested 07/19/21 Pt reports coughing, fatigue, and chest wall muscle pain from coughing 07/20/21 Pt reports mild infrequent dry cough, ongoing fatigue but denies SOB 07/21/21 Pt continues to improve; reports night sweats and inadequate hydration 07/22/21 Pt reports she is feeling better every day but has irregular cough, fatigue, sweats, and tightness in lungs and pain in back of lungs and in right kidney 07/31/21 Pt calls requesting COVID test for work return 08/02/21 Pt presents to screening for COVID test; COVID POSITIVE 08/03/21 Pt reports mild dry cough; clinically resolved
The day following the first dose of the vaccine I felt a slight itch at site of injection. Then on 2/22 at 3:00am I was woken up with swelling on both upper and lower lips. In the morning I observed a large red rash below the injection site, approximately 2 inches round. Later that day I observed welts or hives on both arms, my back, both upper and lower. They were very itchy.  I took 2 capsules (25mg each) of  Allergy Relief (diphenhydramine HCL) twice a day for 4 days and applied  Pain Relief Cream (4% lidocaine) to all itchy areas after showering and before retiring at night to relieve the itching.  The swelling in my lips receded and the rash on my right arm faded. I stopped taking the pills for the next 2 days, but the itch remained so I took the pills at the same dosage and applied the cream as described above for 3 more days and now all symptoms have resolved except for some mild periodic itching on my upper back.
arm pain; Was little confused; Had pain; felt fuggy or maybe like drunk; Felt like chest pressure in her left site; Rapid heartbeat; throat really dry; throat swollen; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Felt like chest pressure in her left site), HEART RATE INCREASED (Rapid heartbeat), DRY THROAT (throat really dry), PHARYNGEAL SWELLING (throat swollen) and PAIN IN EXTREMITY (arm pain) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included NAPROXEN for Arthritis.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced CHEST DISCOMFORT (Felt like chest pressure in her left site), HEART RATE INCREASED (Rapid heartbeat), DRY THROAT (throat really dry), PHARYNGEAL SWELLING (throat swollen) and FEELING ABNORMAL (felt fuggy or maybe like drunk). On 06-Mar-2021, the patient experienced CONFUSIONAL STATE (Was little confused) and PAIN (Had pain). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain). At the time of the report, CHEST DISCOMFORT (Felt like chest pressure in her left site), HEART RATE INCREASED (Rapid heartbeat), DRY THROAT (throat really dry), PHARYNGEAL SWELLING (throat swollen), PAIN IN EXTREMITY (arm pain), FEELING ABNORMAL (felt fuggy or maybe like drunk), CONFUSIONAL STATE (Was little confused) and PAIN (Had pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment of the events included loratadine.
Narrative: Fever, Diarrhea, Congestion, cough, earache, sore throat
suspected vaccination failure; break out around waist; itch; red; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (twice).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pruritus and erythema. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles, pruritus and erythema were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pruritus and erythema to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. After having shingles twice, the patient got the shingles shots. At the time of reporting, the patient was still having trouble, break out around waist and itch. There were no sores and it was just red. This case was considered as suspected vaccination failure, since the details regarding completion of primary vaccination schedule, time to onset for event and laboratory confirmation of shingles were not provided.
I had gout and elevated AFP numbers. I was also diagnosed with esophageal cancer which I had before being vaccinated.
Patient received Pfizer COVID vaccine on 5/8/21, 5/29/21, and 11/30/21. On 12/4/22, patient admitted to our facility for HFNC treatment diagnosed with acute respiratory failure with hypoxia, pneumonia due to COVID-19 virus, and viral pneumonia at risk for bacterial superinfection (diagnosed with influenza A infection 5 days ago and treated with Tamiflu). As of today (12/8/22), patient is still admitted in the ICU.
In addition to the sore arm expected for 5 days, I had a shingles-like itchy rash breakout on my abdomen. It is not listed in typical side effects on your website but perhaps should be.
Patient received the 2nd COVID vaccine (Pfizer, Lot #: EW0185 and expiration date: 08/31/2021) on the left arm at 0918. Patient hailed medics attention and complained of "nausea, seeing purple, and lightheadedness" at 0921. Patient was conscious, alert, and oriented x4. Patient's skins were normal for ethnicity, moisture and temperature. Pupils were equal, accommodating, and reactive to light. Patient appeared anxious and was coached by medic on her breathing. Signs and symptoms began about 2 minutes status post vaccine, but patient claimed no previous reaction with 1st dose. Patient denied any pertinent medical history, allergies, or medications. At 0923 patient was still conscious, alert, and oriented x4 and pupils were still equal, accommodating, and reactive to light. Patient then complained of "seeing everything in purple color," then stated she "could not see anything at all." Medic held up 5 fingers and patient advised she could not see them. Patient began to look pale and skins felt moist and warm. Patient was able to walk with assistance to anti- gravity chair. Nurse then responded to Medic with patient. Baseline vital signs were taken by Medic at 0926, while patient was sitting: blood pressure: 98/60, heart rate: 60, respiratory rate: 16. Patient stated that she runs cross country and that these vital signs were of normal range for her. Patient was given water to sip on. Color and moisture of skins were slowly pinking/drying up. Patient initially experienced nausea and lightheadedness but denied chest pain, shortness of breath, headache, dizziness, or blurry vision. Nurse informed the patient's mother, who was waiting outside, of the situation and brought the mother inside to the patient. At 0935, patient was able to stand her own, with a steady stance. A second set of vitals were taken: blood pressure: 100/64, heart rate: 60, respiratory rate: 14. Patient was negative for orthostatic pressures. Patient stated that symptoms had resolved and that she "felt better, just tired." Patient remained in the observation area for an additional 15 minutes. Patient was conscious, alert, and oriented x4 and skins were normal for ethnicity, moisture, and temperature at 0949. Patient able to walk on her own accord with a steady gait. Mother was driving personal vehicle. Mother and patient were educated on when to contact their primary care physician with any other concerns and when to call 911 if symptoms warrant or when go to ED.
Upon arrival for second dose individual reported rash itching and fever following first dose. Seen by Dr and second dose deferred until seen by an allergist
Varicella vaccine 6/10/10. Next day had cough, fever, fussy. Within 3 days after shot, developed chicken pox rash.
Day after vaccine, left deltoid and upper trapezius swelling radiating to neck. Left supraclavicular adenopathy. Symptoms persisting x6d despite ibuprofen 600mg TID and topical treatment, when presented to office.
Call from client stating symptoms of numbness/facial paralysis on 3:30 PM on 12/18/09. Advised client to call health care provider. They told her to go to ER. ER saw her and diagnosed Bells Palsy. On 12/18 she said they told her was probably not from vaccine. She was treated with prednisone and antivirals and sent home.
Pt recvd vax & was found to be HBSAG pos; blood specimen (drawn 30aUG92) had hemolyzed; Reporter indicated that this result was assumed to be a false pos due to lab error;
Patient experienced immediately swelling at time of injection, however the swelling resolved within a few minutes with no pain, redness or rash reported after follow up.
Patient reports she arm is more sensitive this time with he 2nd COVID booster shot; gum sensitivity; Patient also reports emotional lability where she may be laughing, but is also crying and feels sad simultaneously; Patient also reports low appetite since starting Lenvima; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): EC-2022-112870.  A 69-year-old female patient received BNT162b2 (BNT162B2), as dose 2 (booster), single (Batch/Lot number: unknown) for covid-19 immunization; lenvatinib mesilate (LENVIMA), since 07Apr2022 (Batch/Lot number: unknown) at 14 mg. The patient's relevant medical history included: "endometrial cancer" (unspecified if ongoing), notes: C54.1. The patient's concomitant medications were not reported. Past drug history included: Keytruda. Vaccination history included: Covid-19 vaccine (DOSE X; MANUFACTURER UNKNOWN), for covid-19 immunisation. The following information was reported: VACCINATION SITE HYPERSENSITIVITY (non-serious), outcome "unknown", described as "Patient reports she arm is more sensitive this time with he 2nd COVID booster shot"; GINGIVAL PAIN (non-serious), outcome "unknown", described as "gum sensitivity"; AFFECT LABILITY (non-serious), outcome "unknown", described as "Patient also reports emotional lability where she may be laughing, but is also crying and feels sad simultaneously"; DECREASED APPETITE (non-serious), outcome "unknown", described as "Patient also reports low appetite since starting Lenvima". The action taken for lenvatinib mesilate was unknown.  Additional information: Patient received the Pfizer brand 2nd booster. Patient reports gum sensitivity. Her issue with small toe was not an in grown toenail and HCP is assisting he with fixing that issue. She also reports difficulty when trying to pop her ears as she used to. Patient uses saline nose spray to help with this issue. Patient also reports emotional lability where she may be laughing, but is also crying and feels sad simultaneously. Patient also reports low appetite since starting Lenvima. She feels her overall nutrition is still good at this time. She does think these things are related to Lenvima.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pain where shot admin hour after inj. 2 hrs later muscle aches, middle of night body chills, fever 100.8, raspy throat, muscle aches and joint pain.  Still have muscle soreness and joint pain , throat not raspy just scratchy.  Temp 99.6., still have chills.
The day after the GARDASIL vaccine, patient was very pale and extremely tired. She began complaining of headaches, dizziness, stomach pain, lack of appetite, extreme fatigue, weakness, numbness and tingling in her extremities, and trouble sleeping immediately after and in the weeks/months following vaccine. She was a honor student and star athlete. Overnight she changed. She no longer had the strength or energy to pursue sports, and now she struggles with her school work.
Per patient she got a rash on her face, shoulder, chest and arm after vaccination. She also had nausea and a severe sour taste in her mouth. She also had a severe headache with blurry vision.
Patient woke up the next day with fever, chills, headache, and muscle aches. She went to hospital because she thought she had the flu. She was checked with EKG, flu test, and other exams all negative. She had chest x-ray negative. She got IV fluids and took TYLENOL. She felt better after 6-12 hours on TYLENOL.
On 15Jan2021, I became infected with COVID and my test became positive; This is a spontaneous report from a contactable physician (patient, specialty: Internal Medicine). A 48-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), dose 1 via an unspecified route of administration on 05Jan2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Physician reported that he received his first dose of the Pfizer-BioNTech COVID-19 Vaccine on 05Jan2021. On 15Jan2021, he became infected with COVID and his test became positive so he did not take the second dose yet. He was trying to determine timing of his second dose at this time. The patient underwent lab tests and procedures which included SARs-COV-2 test with result positive  on 15Jan2021 The outcome of the event was unknown.   Information about Lot/batch number has been requested.
Developed numbness/tingling in hands/feet on 10/18. Went to PCP 10/19 who sent to hospital ER. Sx's got worse, went back on 10/20 and got admitted. Had lap chole. Sx's worse saw neuro who dx'd with CIDP. to f/u outpt. Sx's worse with increased pain in arms, legs, back. Taken to ER. Unresponsive when arrived to ER. Intubated, then had cardiac arrest. LP done and dx'd with Guillain Barre.
Pts mom called 30 minutes after arriving home from the clinic to say pt had large hives on arms and legs. Pt was brought back to clinic. Exam showed large, red hives on extremities, not on trunk. Mom advised to treat with Benadryl and called later to say that hives had disappeared by the time she arrived home.
Mother called 7/13/05 at 1:30 PM, left message on voice mail, stated child 's leg was red,  swollen & "itchy". I was out of office all afternoon at clinic, returned call at 8AM 7/14/05. Mother reports leg less red and itchy today, but last night child c/o throat "feels funny". Mother checked throat, states it looked swollen, but not red.Reports today child is "acting  normal",eating, drinking, playing, has no fever, but is "acting tired". All symptoms seem  "a little better" today. Advised to contact physician this morning, or to ER if s/s increase especially throat swelling. Additional information, PHN in office relates that mother talked with office staff yesterday regarding child, apparently only reported leg redness and itching.  Was instructed to call physician regarding symtpoms.